药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Sunitinib.
Benzonatate
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Sunitinib.
Benzonatate
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Sunitinib.
Benzonatate
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Sunitinib.
Benzonatate
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Sunitinib.
Benzonatate
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Sunitinib.
Benzonatate
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Sunitinib.
Benzonatate
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Sunitinib.
Benzonatate
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Sunitinib.
Benzonatate
Terodiline
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Terodiline.
Benzonatate
Macimorelin
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Macimorelin.
Benzonatate
Glasdegib
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Glasdegib.
Benzonatate
Ivabradine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Ivabradine.
Benzonatate
Asenapine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Asenapine.
Benzonatate
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Tetrabenazine.
Benzonatate
Temafloxacin
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Temafloxacin.
Benzonatate
Lithium cation
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lithium cation.
Benzonatate
Clorgiline
Clorgiline may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Brofaromine
Brofaromine may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Harmaline
Harmaline may increase the hypoglycemic activities of Sunitinib.